CDKN2A and precursor B-cell acute lymphoblastic leukemia: CDKN2A/B (31%), IKZF1 (16%), ETV6 (12%), ERG (12%), and RB1 (11%) were the most common CNV in B-ALL (Supplement Fig. S8).